Last reviewed · How we verify
NCT07389226
The Effect of Apple Cider Vinegar Supplementation on 24-hour Urine Chemistry in Adults
NA trial testing Apple Cider Vinegar in Kidney Stones in 30 participants. Not yet recruiting.
1 January 2028
Quick facts
| Lead sponsor | University of Chicago |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 1 May 2026 |
| Primary completion | 1 January 2028 |
| Estimated completion | 1 February 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Apple Cider Vinegar — full drug profile →
Conditions studied
- Kidney Stones — all drugs for Kidney Stones →
- Urine Specimen Collection — all drugs for Urine Specimen Collection →
Sponsor
University of Chicago
Who can join
18 and older, any sex, with Kidney Stones or Urine Specimen Collection. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Measure changes in citrate in urine.
Time frame: From Enrollment to 2 weeks
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry. -
Measure changes in Urine PH
Time frame: From enrollment to 2 weeks
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry. -
Measure changes in calcium in urine.
Time frame: from enrollment to 2 weeks
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry. -
Measure changes in calcium oxalate in urine
Time frame: From Enrollment to 2 weeks
to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Sponsor's own description
This is a single-center prospective cohort study to evaluate the effect of short-term daily apple cider vinegar (ACV) supplementation on urine chemistry.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07389226
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Apple Cider Vinegar
Trials testing the same drug.
- NCT07365956 — Comparison of Oral Care Solutions on Oral Microbial Colonization in Neurosurgical ICU Patients · NA · completed
- NCT04073719 — Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL) · NA · unknown
Other recruiting trials for Kidney Stones
Currently open trials in the same condition.
- NCT07492147 — Effect of Negative Pressure Suction on Fluid Absorption and Infection in Flexible Ureteroscopy · recruiting
- NCT07332286 — FANS-Assisted Mini-PCNL for Complex Renal Stones · NA · active not recruiting
- NCT07055282 — SGLT2i in Kidney Stones · EARLY_PHASE1 · recruiting
- NCT07225764 — CaOx Stone Prevention · Phase 4 · recruiting
- NCT07159035 — Flexible Ureteroscopy With a Flexible and Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithot · NA · recruiting
Other University of Chicago trials
Trials by the same sponsor.
- NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
- NCT07354100 — Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy · Phase 1, PHASE2 · not yet recruiting
- NCT06446661 — Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia · NA · not yet recruiting
- NCT07179315 — A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Tr · Phase 2 · not yet recruiting
- NCT07126561 — Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07389226 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Chicago
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07389226.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing